{"id":53036,"date":"2023-01-18T15:02:23","date_gmt":"2023-01-18T14:02:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/"},"modified":"2023-01-18T15:02:23","modified_gmt":"2023-01-18T14:02:23","slug":"cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/","title":{"rendered":"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board"},"content":{"rendered":"
\n

SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced that Jonathan Talamo, MD has been appointed as its new Chair of the Board of Directors. Dr. Talamo has served as a Board Member for the company since 2020.\n<\/p>\n

<\/a><\/p>\n

\nDr. Talamo, an ophthalmic surgeon with over 25 years in clinical practice, is a leader in corneal disease, cataract, and refractive surgery. After 25 years in the clinic, he pivoted to executive roles in biomedicine and healthcare. As Chief Medical Officer of Ocular Therapeutix, Dr. Talamo helped usher the development of Dextenza for post-surgical inflammation and managed a pipeline of ophthalmologic therapeutics. In his subsequent role as Chief Medical Officer and Worldwide Vice President of Clinical and Medical Affairs at Johnson & Johnson Vision, Dr. Talamo helped lead the integration of Abbott Medical Optics and the global launch of multiple ophthalmologic products.\n<\/p>\n

\n\u201cI am thrilled to work more closely with the CXLO Board as we develop the minimally-invasive EpiSmart cross-linking system to improve patient comfort and preserve vision,\u201d said Dr. Talamo. \u201cI look forward to collaborating with the CXLO team to improve safety and clinical outcomes for patients with keratoconus.\u201d\n<\/p>\n

\n\u201cWith a career spanning ophthalmic surgery to therapeutic development and industry leadership, Jon brings a wealth of experience to our Board,\u201d commented Michael D. Webb, President and Chief Executive Officer of CXL Ophthalmics. \u201cWe look forward to Jon\u2019s leadership as CXLO strives to deliver safer and more accessible care globally to the millions of patients at risk of vision loss due to keratoconus.\u201d\n<\/p>\n

\nAbout CXL Ophthalmics<\/b>\n<\/p>\n

\nCXLO is developing a minimally-invasive treatment for ectatic corneal disease that can bring early intervention to millions of patients globally. Our EpiSmart approach is a transformative cross-linking system designed to treat keratoconus without disrupting the epithelium, allowing for a rapid return to normal activities.\n<\/p>\n

\nFor more information, please visit www.cxlophthalmics.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
\n<\/b>
Tara Mulloy
\n
MacDougall Advisors
\n
(978) 855-5219
\n
tmulloy@macdougall.bio<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced that Jonathan Talamo, MD has been appointed as its new Chair of the Board of Directors. Dr. Talamo has served as a Board Member for the company since 2020. Dr. Talamo, an ophthalmic surgeon with over 25 years in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53036","6":"format-standard","7":"category-industry"},"yoast_head":"\nCXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced that Jonathan Talamo, MD has been appointed as its new Chair of the Board of Directors. Dr. Talamo has served as a Board Member for the company since 2020. Dr. Talamo, an ophthalmic surgeon with over 25 years in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-18T14:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230118005006\/en\/1579225\/21\/CXLOphthalmics-logo_highcontrast.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board\",\"datePublished\":\"2023-01-18T14:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/\"},\"wordCount\":335,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005006\\\/en\\\/1579225\\\/21\\\/CXLOphthalmics-logo_highcontrast.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/\",\"name\":\"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005006\\\/en\\\/1579225\\\/21\\\/CXLOphthalmics-logo_highcontrast.jpg\",\"datePublished\":\"2023-01-18T14:02:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005006\\\/en\\\/1579225\\\/21\\\/CXLOphthalmics-logo_highcontrast.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005006\\\/en\\\/1579225\\\/21\\\/CXLOphthalmics-logo_highcontrast.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/","og_locale":"en_US","og_type":"article","og_title":"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board - Pharma Trend","og_description":"SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced that Jonathan Talamo, MD has been appointed as its new Chair of the Board of Directors. Dr. Talamo has served as a Board Member for the company since 2020. Dr. Talamo, an ophthalmic surgeon with over 25 years in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-18T14:02:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230118005006\/en\/1579225\/21\/CXLOphthalmics-logo_highcontrast.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board","datePublished":"2023-01-18T14:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/"},"wordCount":335,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005006\/en\/1579225\/21\/CXLOphthalmics-logo_highcontrast.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/","url":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/","name":"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005006\/en\/1579225\/21\/CXLOphthalmics-logo_highcontrast.jpg","datePublished":"2023-01-18T14:02:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230118005006\/en\/1579225\/21\/CXLOphthalmics-logo_highcontrast.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230118005006\/en\/1579225\/21\/CXLOphthalmics-logo_highcontrast.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cxl-ophthalmics-appoints-jonathan-talamo-md-as-chair-of-the-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53036"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53036\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}